Active ingredients
Pharmacological Group
Used in the treatment
- G93.4 Encephalopathy, unspecified
- F79 Unspecified mental retardation
- F45 Somatoform disorders
- F44 Dissociative [conversion] disorders
- F43.2 Adjustment disorders
- F43.1 Post-traumatic stress disorder
- F43.0 Acute stress reaction
- F42 Obsessive-compulsive disorder
- F41.1 Generalized anxiety disorder
- F41.0 Panic disorder [episodic paroxysmal anxiety]
- F40.0 Agoraphobia
- F40.1 Social phobias
- F34.0 Cyclothymia
- F34.1 Dysthymia
- F32 Depressive episode
- F29 Unspecified nonorganic psychosis
- F25 Schizoaffective disorders
- F11.2 Mental and behavioural disorders due to use of opioids, dependence syndrome
- F10.2 Mental and behavioural disorders due to use of alcohol, dependence syndrome
- F10.3 Mental and behavioural disorders due to use of alcohol, withdrawal state
- F06.4 Organic anxiety disorder
- F06 Other mental disorders due to brain damage and dysfunction and to physical disease
- F11 Mental and behavioural disorders due to use of opioids
- F40 Phobic anxiety disorders